Dialog, a Thomson business, has added data on adverse drug events to the collection of pharmaceutical industry news and research available through its family of online services.
Researchers, regulatory compliance and quality control professionals, product development specialists and others in the pharmaceutical industry, as well as doctors, regulators and legal practitioners focused on drugs, healthcare and related topics, use Dialog and its sister service Dialog DataStar to conduct in-depth research, track industry news and monitor competitors.
“The great advantages of Dialog and Dialog DataStar are the breadth of the information offered under one umbrella and our ability to package the information in the most usable formats,” said Viji Krishnan, vice president of publisher management for Dialog. “–The addition of the adverse drug events data underscores our commitment to ongoing enhancements to our pharmaceutical content collection.”
Dialog: www.dialog.com
